0 0 0 0 0 0 0 -0.00072411296162204
Sign Up Today X
Thanks for submitting the form.
Stockreport

Why Gilead Sciences (GILD) Stock Is Up Today [Yahoo! Finance]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
as the company announced a series of positive developments, including successful late-stage trial results for a new HIV treatment, regulatory approval for another HIV drug in the U.K., and a new pricing agreement with the U.S. government. Gilead reported that its investigational single-tablet regimen for HIV, which combined bictegravir and lenacapavir, met its primary goal in a phase III study, boosting its chances for future approval. Adding to the good news, the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) approved lenacapavir for preventing sexually transmitted HIV-1 infection, marking the introduction of a long-acting, six-month preventative option. Furthermore, Gilead reached a three-year agreement with the U.S. government to offer discounted pricing on existing and future medicines, including treatments for HIV, Hepatitis, and COVID-19. After the initial pop the shares cooled down to $124.46, up 2.5% from previous close. Is now the time to buy Gilead S [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

Why Gilead Sciences (GILD) Stock Is Up Today [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
as the company announced a series of positive developments, including successful late-stage trial results for a new HIV treatment, regulatory approval for another HIV drug in the U.K., and a new pricing agreement with the U.S. government. Gilead reported that its investigational single-tablet regimen for HIV, which combined bictegravir and lenacapavir, met its primary goal in a phase III study, boosting its chances for future approval. Adding to the good news, the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) approved lenacapavir for preventing sexually transmitted HIV-1 infection, marking the introduction of a long-acting, six-month preventative option. Furthermore, Gilead reached a three-year agreement with the U.S. government to offer discounted pricing on existing and future medicines, including treatments for HIV, Hepatitis, and COVID-19. After the initial pop the shares cooled down to $124.46, up 2.5% from previous close. Is now the time to buy Gilead S [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS